The nature and magnitude of inflammation was found to be negatively correlated with survival of cancer patients [12]; a higher neutrophil count is linked to an impaired anti-tumor immune response, augmented synthesis and systemic release of vascular endothelial growth factor (VEGF) [13] which plays a pivotal role in tumor angiogenesis and hence higher tumor recurrence rates [14]. Here, VEGFA is linked to cancer.